Yahoo Finance Kineta Second Quarter 2023 Earnings: Beats Expectations
Kineta (NASDAQ:KA) Second Quarter 2023 Results
Key Financial Results
Revenue: US$5.16m (up by US$4.33m from 2Q 2022).
Net income: US$386.0k (up from US$5.88m loss in 2Q 2022).
Profit margin: 7.5% (up from net loss in 2Q 2022).
EPS: US$0.039 (up from US$1.23 loss in 2Q 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Kineta Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates significantly. Earnings per share (EPS) also surpassed analyst estimates.
Looking ahead, revenue is expected to decline by 116% p.a. on average during the next 3 years, while revenues in the Biotechs industry in the US are expected to grow by 15%.
Performance of the American Biotechs industry.
The company's shares are down 12% from a week ago.
Risk Analysis
Before we wrap up, we've discovered 4 warning signs for Kineta (1 is a bit concerning!) that you should be aware of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
